Related Experiment Video
Updated: Oct 25, 2025

06:51
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
2.9K
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Lisha Wang1, Liza Bergkvist1, Rajnish Kumar2
1Department of Neuroscience Care and Society, Division of Neurogeriatrics, Karolinska Institutet.
Journal of Visualized Experiments : Jove
|August 9, 2021
Summary
Researchers developed a new assay to block heat shock protein 90 (Hsp90) interactions with co-chaperones FKBP51 and FKBP52. This method identified inhibitors targeting Hsp90-FKBP51 interactions, offering therapeutic potential for diseases.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- Heat shock protein 90 (Hsp90) is crucial for cellular processes, and its interactions with co-chaperones like FKBP51 and FKBP52 are key targets.
- The C-terminal MEEVD pentapeptide of Hsp90 mediates binding to the tetratricopeptide repeat (TPR) motif of co-chaperones.
- FKBP51 and FKBP52, despite structural similarities, have distinct roles in steroid hormone-dependent diseases, making selective targeting important.
Purpose of the Study:
- To develop and validate an assay for probing Hsp90-cochaperone interactions.
- To screen for small molecules that selectively inhibit Hsp90-FKBP51 or Hsp90-FKBP52 interactions.
- To identify potent and selective inhibitors of Hsp90-FKBP51 interactions for therapeutic applications.
Main Methods:
- Purification of glutathione S-transferase (GST)-tagged FKBP51 and FKBP52 proteins containing the TPR motif.
- Development of an amplified luminescent proximity homogenous assay (ALPHA) using GST-fused TPR proteins and an Hsp90 C-terminal peptide.
- Screening of small molecules using the ALPHA assay to identify inhibitors of Hsp90-FKBP51/52 interactions.
Main Results:
- Successfully purified GST-tagged FKBP51 and FKBP52.
- Established a homogeneous ALPHA assay to detect Hsp90-cochaperone interactions.
- Identified potent and selective small molecule inhibitors of Hsp90-FKBP51 interactions through screening.
Conclusions:
- The developed ALPHA assay is effective for probing Hsp90-cochaperone interactions.
- Selective inhibition of Hsp90-FKBP51 interactions is achievable.
- This approach holds significant therapeutic potential for diseases involving Hsp90-FKBP51/52 pathways.

